PT2201002E - Antagonistas de receptores 5-ht7 - Google Patents

Antagonistas de receptores 5-ht7 Download PDF

Info

Publication number
PT2201002E
PT2201002E PT08836911T PT08836911T PT2201002E PT 2201002 E PT2201002 E PT 2201002E PT 08836911 T PT08836911 T PT 08836911T PT 08836911 T PT08836911 T PT 08836911T PT 2201002 E PT2201002 E PT 2201002E
Authority
PT
Portugal
Prior art keywords
methyl
tetrahydro
ylmethyl
pyrazol
mmol
Prior art date
Application number
PT08836911T
Other languages
English (en)
Portuguese (pt)
Inventor
Sandra Ann Filla
Valentina O Badescu
Peter Thaddeus Gallagher
Maria Ann Whatton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT2201002E publication Critical patent/PT2201002E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT08836911T 2007-10-12 2008-09-30 Antagonistas de receptores 5-ht7 PT2201002E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12

Publications (1)

Publication Number Publication Date
PT2201002E true PT2201002E (pt) 2012-04-27

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08836911T PT2201002E (pt) 2007-10-12 2008-09-30 Antagonistas de receptores 5-ht7

Country Status (19)

Country Link
US (1) US7910588B2 (cg-RX-API-DMAC7.html)
EP (1) EP2201002B1 (cg-RX-API-DMAC7.html)
JP (1) JP5291716B2 (cg-RX-API-DMAC7.html)
KR (1) KR101161070B1 (cg-RX-API-DMAC7.html)
CN (1) CN101821257B (cg-RX-API-DMAC7.html)
AT (1) ATE548365T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008311154B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818450A2 (cg-RX-API-DMAC7.html)
CA (1) CA2699674C (cg-RX-API-DMAC7.html)
CY (1) CY1112709T1 (cg-RX-API-DMAC7.html)
DK (1) DK2201002T3 (cg-RX-API-DMAC7.html)
EA (1) EA016787B1 (cg-RX-API-DMAC7.html)
ES (1) ES2380756T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20120257T1 (cg-RX-API-DMAC7.html)
MX (1) MX2010003986A (cg-RX-API-DMAC7.html)
PL (1) PL2201002T3 (cg-RX-API-DMAC7.html)
PT (1) PT2201002E (cg-RX-API-DMAC7.html)
SI (1) SI2201002T1 (cg-RX-API-DMAC7.html)
WO (1) WO2009048765A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
MX2014004210A (es) 2011-10-11 2014-05-28 Ucb Pharma Sa Derivados de 2-oxo-piperidinilo.
ES2804545T3 (es) 2013-03-11 2021-02-08 Univ Temple Nuevos moduladores de la actividad del receptor de 5-hidroxitriptamina 7 y su método de uso
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
EP3200589A4 (en) 2014-09-10 2018-07-25 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
KR102900157B1 (ko) 2016-11-15 2025-12-12 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 5-히드록시트립타민 수용체 7의 신규 조절제 및 이의 사용 방법
JP7365238B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
WO2004067703A2 (en) * 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
JP2008501031A (ja) 2004-05-28 2008-01-17 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
KR20100054853A (ko) 2010-05-25
EA201070462A1 (ru) 2010-10-29
CN101821257A (zh) 2010-09-01
JP5291716B2 (ja) 2013-09-18
CA2699674A1 (en) 2009-04-16
AU2008311154B2 (en) 2013-09-26
EA016787B1 (ru) 2012-07-30
AU2008311154A1 (en) 2009-04-16
CN101821257B (zh) 2013-05-22
BRPI0818450A2 (pt) 2015-05-12
JP2011500575A (ja) 2011-01-06
SI2201002T1 (sl) 2012-04-30
US20100197700A1 (en) 2010-08-05
ATE548365T1 (de) 2012-03-15
DK2201002T3 (da) 2012-04-10
CY1112709T1 (el) 2016-02-10
EP2201002B1 (en) 2012-03-07
US7910588B2 (en) 2011-03-22
HRP20120257T1 (hr) 2012-04-30
CA2699674C (en) 2013-07-16
EP2201002A1 (en) 2010-06-30
ES2380756T3 (es) 2012-05-18
WO2009048765A1 (en) 2009-04-16
KR101161070B1 (ko) 2012-07-13
PL2201002T3 (pl) 2012-07-31
MX2010003986A (es) 2010-04-27

Similar Documents

Publication Publication Date Title
ES2395872T3 (es) 2-[4-(Pirazol-4-ilalquil)piperazin-1-il]-3-fenil pirazinas y piridinas y 3-[4-(pirazol-4-ilalquil)piperazin-1-il]-2-fenil piridinas como antagonistas del receptor de 5-HT7
PT2201002E (pt) Antagonistas de receptores 5-ht7
WO2015152367A1 (ja) オキソ複素環誘導体
JPWO2013187466A1 (ja) 分岐鎖アルキルヘテロ芳香環誘導体
EP1265870A1 (en) New ccr5 modulators: benzimidazoles or benzotriazoles
JP5685440B2 (ja) 3位において二置換されているインドール−2−オン誘導体、これらの調製およびこれらの治療上の使用
AU2008293715B2 (en) Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists
CN101124216A (zh) 杂环MCHr1拮抗剂及其在治疗中的用途